22. Which of the following is an example of a drug utilization review issue?
Answer: D
A prescribed dose is higher than the standard dose
This scenario exemplifies a drug utilization review issue, as it involves evaluating whether the prescribed medication dose exceeds the recommended standard dose, which could pose safety risks to the patient.
A) A drug error report is generated for analysis
While generating a drug error report is important for identifying and rectifying medication errors, it does not specifically address the appropriateness of drug utilization in terms of dosing or adherence to guidelines. Therefore, it is not an example of a drug utilization review issue.
B) A generic product is substituted for the brand product
Substituting a generic product for a brand product is a common practice aimed at cost-saving and does not inherently indicate a review issue regarding drug utilization. This process is typically an acceptable practice as long as it meets regulatory standards, hence it does not qualify as a drug utilization review issue.
C) A medication dose is within range for an OTC product
When a medication dose is confirmed to be within the appropriate range for an over-the-counter (OTC) product, it reflects proper utilization rather than an issue. This scenario indicates compliance with dosing guidelines rather than a concern necessitating review, making it incorrect in the context of drug utilization review issues.
D) A prescribed dose is higher than the standard dose
This option directly identifies a potential problem in drug utilization, as prescribing a dose that exceeds the standard recommendations raises concerns about patient safety and efficacy. Such a situation warrants thorough review and intervention to prevent adverse outcomes.
Conclusion
The correct answer highlights a critical aspect of medication safety by pointing out that a prescribed dose exceeding standard guidelines can lead to significant health risks. Options A, B, and C do not represent issues related to drug utilization review, as they either pertain to error reporting or acceptable practices. Thus, option D stands out as the only choice that directly addresses a potential concern in medication management.